comparison of glp-1 agonists for weight loss vs bariatric surgery Metabolic and versus glucagon-like peptide-1 receptor agonist therapy: A cardiovascular outcomes in patients with obesity Bariatric Surgery Yields 5x More – Comparison of the GIP a

Aggregated peptides lose biological activity and can produce unpredictable or immunogenic responses if administered

THE RESULTS Visible results can be seen within a few weeks as the body metabolises the broken-down fat cells

Patients with Fitzpatrick IV to VI should consult their dermatologist before starting because of the elevated risk of post-inflammatory hyperpigmentation in darker skin tones

Glucagon-like peptide-1-based therapy is a popular treatment for type 2 diabetes

Kruhlak NL, Schmidt M, Froetschl R et al (2024) Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: development and application of the Carcinogenic Potency Categorization Approach (CPCA)

Only in very rare cases where an inadvertent rechallenge occurs do symptoms appear within hours